TrialThe Journal of allergy and clinical immunology2025
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy.
Jessica R Humphrey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.